Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in colorectal cancer in Chile: a 3-year real-world evidence [2019-2021]-a brief report.

Journal of gastrointestinal oncology·2026
Same author

Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study.

European journal of internal medicine·2026
Same author

MicroRNA-597 Suppresses Gastric Cancer Invasion and Progression via <i>RUNX1</i> Targeting, an Effect Attenuated by the Long Non-Coding RNA <i>KCNQ1OT1</i>.

International journal of molecular sciences·2026
Same author

Bridging technology and pedagogy: evaluation of an interprofessional course on technology-enhanced learning for health professions educators.

Frontiers in medicine·2026
Same author

Helicobacter pylori infection activates the HIF-1α/ALS2/Rab5 signaling axis in gastric cells.

Cell communication and signaling : CCS·2026
Same author

Persistent elevated thyroglobulin revealing Struma ovarii in a patient treated for papillary thyroid carcinoma: A case report.

Medwave·2026

Related Experiment Video

Updated: Oct 14, 2025

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.1K

[Update on neuroendocrine tumors].

Diego Carrillo1, Matías Muñoz-Medel1, Ignacio Retamal1

  • 1Departamento de Hematología-Oncología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Revista Medica De Chile
|November 9, 2021
PubMed
Summary

Neuroendocrine Tumors (NETs) are increasingly common digestive tract cancers. Advances in diagnosis and treatment, including new drugs, are improving patient outcomes but present healthcare challenges.

More Related Videos

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

19.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.2K

Related Experiment Videos

Last Updated: Oct 14, 2025

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.1K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

19.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.2K

Area of Science:

  • Oncology
  • Endocrinology
  • Gastroenterology

Background:

  • Neuroendocrine Tumors (NETs) originate from neuroendocrine cells and produce bioactive substances.
  • NETs are increasingly diagnosed, particularly within the digestive tract.
  • Carcinoid syndrome, a common NET manifestation, involves diarrhea, flushing, and cardiac issues.

Purpose of the Study:

  • To summarize recent advancements in the classification, diagnosis, and treatment of Neuroendocrine Tumors.
  • To highlight the evolving understanding and management strategies for NETs.
  • To underscore the importance of a multidisciplinary approach in NET care.

Main Methods:

  • Review of recent research and clinical findings in Neuroendocrine Tumor management.
  • Analysis of updated classifications and diagnostic criteria for NETs.
  • Evaluation of therapeutic outcomes with somatostatin analogues, radiation, biological, and cytotoxic agents.

Main Results:

  • Significant increase in NET incidence, establishing them as common digestive tract tumors.
  • Diverse clinical presentations linked to varied hormone production capabilities.
  • Improved prognosis for patients due to advancements in treatment modalities.

Conclusions:

  • Recent research has reshaped the understanding and classification of NETs.
  • A multidisciplinary approach is crucial for effective NET diagnosis and treatment.
  • Emerging therapies offer improved outcomes, posing new challenges for healthcare systems.